| MeSH term | MeSH ID | Detail |
|---|---|---|
| Nervous System Diseases | D009422 | 37 associated lipids |
| Enterocolitis, Pseudomembranous | D004761 | 8 associated lipids |
| Ataxia | D001259 | 20 associated lipids |
| Psoriasis | D011565 | 47 associated lipids |
| Urinary Tract Infections | D014552 | 11 associated lipids |
| Cross Infection | D003428 | 9 associated lipids |
| Pseudomonas Infections | D011552 | 25 associated lipids |
| Staphylococcal Skin Infections | D013207 | 9 associated lipids |
| Wound Infection | D014946 | 12 associated lipids |
| Bacteriuria | D001437 | 7 associated lipids |
erythromycin
erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.
Cross Reference
Introduction
To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with erythromycin?
erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
- Antimicrob. Agents Chemother. (35)
- J. Antimicrob. Chemother. (18)
- Clin. Infect. Dis. (2)
- Others (29)
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with erythromycin
PubChem Associated disorders and diseases
What pathways are associated with erythromycin
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with erythromycin?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with erythromycin?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with erythromycin?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with erythromycin?
Related references are published most in these journals:
- Antimicrob. Agents Chemother. (19)
- J. Antimicrob. Chemother. (10)
- Drug Metab. Dispos. (5)
- Others (29)
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with erythromycin?
Mouse Model
Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).
Knock-out
Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with erythromycin
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Hoban DJ et al. | Macrolide-resistant Streptococcus pneumoniae in Canada during 1998-1999: prevalence of mef(A) and erm(B) and susceptibilities to ketolides. | 2001 | Antimicrob. Agents Chemother. | pmid:11408241 |
| Nilius AM et al. | Comparative in vitro activity of ABT-773, a novel antibacterial ketolide. | 2001 | Antimicrob. Agents Chemother. | pmid:11408246 |
| Kirven LA and Thornsberry C | Minimum bactericidal concentration of sulfamethoxazole-trimethoprim for Haemophilus influenzae: correlation with prophylaxis. | 1978 | Antimicrob. Agents Chemother. | pmid:310281 |
| Conejo Mdel C et al. | Activities of ABT-773 against Listeria monocytogenes and coryneform bacteria of clinical interest. | 2003 | Antimicrob. Agents Chemother. | pmid:12654678 |
| Ng LK et al. | Can Etest be used to determine Vibrio cholerae susceptibility to erythromycin? | 2003 | Antimicrob. Agents Chemother. | pmid:12654699 |
| Sutcliffe J et al. | Detection of erythromycin-resistant determinants by PCR. | 1996 | Antimicrob. Agents Chemother. | pmid:8913465 |
| Vowels BR et al. | Effects of topical erythromycin on ecology of aerobic cutaneous bacterial flora. | 1996 | Antimicrob. Agents Chemother. | pmid:8913472 |
| van der Linden M et al. | Clonal spread of mef-positive macrolide-resistant Streptococcus pneumoniae isolates causing invasive disease in adults in Germany. | 2007 | Antimicrob. Agents Chemother. | pmid:17325214 |
| O'Hara K and Yamamoto K | Reaction of roxithromycin and clarithromycin with macrolide-inactivating enzymes from highly erythromycin-resistant Escherichia coli. | 1996 | Antimicrob. Agents Chemother. | pmid:8849224 |
| Norris SJ and Edmondson DG | In vitro culture system to determine MICs and MBCs of antimicrobial agents against Treponema pallidum subsp. pallidum (Nichols strain). | 1988 | Antimicrob. Agents Chemother. | pmid:2964810 |
| Doern GV et al. | Emergence of high rates of antimicrobial resistance among viridans group streptococci in the United States. | 1996 | Antimicrob. Agents Chemother. | pmid:8849246 |
| Ishida K et al. | In vitro and in vivo activities of macrolides against Mycoplasma pneumoniae. | 1994 | Antimicrob. Agents Chemother. | pmid:8031048 |
| Arias CA et al. | Cotransfer of antibiotic resistance genes and a hylEfm-containing virulence plasmid in Enterococcus faecium. | 2009 | Antimicrob. Agents Chemother. | pmid:19667280 |
| Nielsen EI et al. | Predicting in vitro antibacterial efficacy across experimental designs with a semimechanistic pharmacokinetic-pharmacodynamic model. | 2011 | Antimicrob. Agents Chemother. | pmid:21282424 |
| Goldman RC and Kadam SK | Binding of novel macrolide structures to macrolides-lincosamides-streptogramin B-resistant ribosomes inhibits protein synthesis and bacterial growth. | 1989 | Antimicrob. Agents Chemother. | pmid:2506804 |
| Lee CK et al. | In vitro assays of the efficacy of antimicrobial agents in controlling Chlamydia trachomatis propagation. | 1978 | Antimicrob. Agents Chemother. | pmid:162541 |
| Pankuch GA et al. | MIC and time-kill study of antipneumococcal activities of RPR 106972 (a new oral streptogramin), RP 59500 (quinupristin-dalfopristin), pyostacine (RP 7293), penicillin G, cefotaxime, erythromycin, and clarithromycin against 10 penicillin-susceptible and -resistant pneumococci. | 1996 | Antimicrob. Agents Chemother. | pmid:8878583 |
| Alcaide F et al. | In vitro activities of eight macrolide antibiotics and RP-59500 (quinupristin-dalfopristin) against viridans group streptococci isolated from blood of neutropenic cancer patients. | 1996 | Antimicrob. Agents Chemother. | pmid:8878591 |
| Zhu W et al. | Vancomycin-resistant Staphylococcus aureus isolates associated with Inc18-like vanA plasmids in Michigan. | 2008 | Antimicrob. Agents Chemother. | pmid:18056272 |
| Zaknoon F et al. | Antibacterial properties of an oligo-acyl-lysyl hexamer targeting Gram-negative species. | 2012 | Antimicrob. Agents Chemother. | pmid:22751534 |
| Camilli R et al. | New genetic element carrying the erythromycin resistance determinant erm(TR) in Streptococcus pneumoniae. | 2008 | Antimicrob. Agents Chemother. | pmid:18070957 |
| Gladue RP and Snider ME | Intracellular accumulation of azithromycin by cultured human fibroblasts. | 1990 | Antimicrob. Agents Chemother. | pmid:2168141 |
| Kataja J et al. | Erythromycin resistance genes in group A streptococci in Finland. The Finnish Study Group for Antimicrobial Resistance. | 1999 | Antimicrob. Agents Chemother. | pmid:9869564 |
| Perronne C et al. | Activities of clarithromycin, sulfisoxazole, and rifabutin against Mycobacterium avium complex multiplication within human macrophages. | 1990 | Antimicrob. Agents Chemother. | pmid:2171421 |
| Mendes RE et al. | In vitro activity of telavancin against a contemporary worldwide collection of Staphylococcus aureus isolates. | 2010 | Antimicrob. Agents Chemother. | pmid:20385851 |
| Mitten MJ et al. | Efficacies of ABT-773, a new ketolide, against experimental bacterial infections. | 2001 | Antimicrob. Agents Chemother. | pmid:11502533 |
| Kenny GE and Cartwright FD | Susceptibilities of Mycoplasma hominis, M. pneumoniae, and Ureaplasma urealyticum to GAR-936, dalfopristin, dirithromycin, evernimicin, gatifloxacin, linezolid, moxifloxacin, quinupristin-dalfopristin, and telithromycin compared to their susceptibilities to reference macrolides, tetracyclines, and quinolones. | 2001 | Antimicrob. Agents Chemother. | pmid:11502536 |
| Dicuonzo G et al. | Erythromycin-resistant pharyngeal isolates of Streptococcus pyogenes recovered in Italy. | 2002 | Antimicrob. Agents Chemother. | pmid:12435707 |
| Mavroidi A et al. | Multidrug-resistant strains of Neisseria gonorrhoeae in Greece. | 2001 | Antimicrob. Agents Chemother. | pmid:11502546 |
| Xu CW et al. | First report of macrolide resistance gene erm(T) harbored by a novel small plasmid from Erysipelothrix rhusiopathiae. | 2015 | Antimicrob. Agents Chemother. | pmid:25666150 |
| Osada Y and Ogawa H | Antimycoplasmal activity of ofloxacin (DL-8280). | 1983 | Antimicrob. Agents Chemother. | pmid:6573869 |
| Saroglou G and Bisno AL | Susceptibility of skin and throat strains of group A streptococci to rosamicin and erythromycin. | 1978 | Antimicrob. Agents Chemother. | pmid:27141 |
| Hardy DJ et al. | Enhancement of the in vitro and in vivo activities of clarithromycin against Haemophilus influenzae by 14-hydroxy-clarithromycin, its major metabolite in humans. | 1990 | Antimicrob. Agents Chemother. | pmid:2143642 |
| Garrett ER and Won CM | Effect of novobiocin and its combination with tetracycline, chloramphenicol, erythromycin, and lincomycin on the microbial generation of Escherichia coli. | 1973 | Antimicrob. Agents Chemother. | pmid:4602829 |
| Hächler H et al. | Genetic characterization of a Clostridium difficile erythromycin-clindamycin resistance determinant that is transferable to Staphylococcus aureus. | 1987 | Antimicrob. Agents Chemother. | pmid:2821888 |
| McCashion RN and Lynch WH | Effects of polymyxin B nonapeptide on Aeromonas salmonicida. | 1987 | Antimicrob. Agents Chemother. | pmid:2823698 |
| Thakker-Varia S et al. | Molecular epidemiology of macrolides-lincosamides-streptogramin B resistance in Staphylococcus aureus and coagulase-negative staphylococci. | 1987 | Antimicrob. Agents Chemother. | pmid:3038007 |
| Goldstein EJ et al. | Lack of in vitro efficacy of oral forms of certain cephalosporins, erythromycin, and oxacillin against Pasteurella multocida. | 1988 | Antimicrob. Agents Chemother. | pmid:3364944 |
| Hedberg ST et al. | Antibiotic susceptibility and characteristics of Neisseria meningitidis isolates from the African meningitis belt, 2000 to 2006: phenotypic and genotypic perspectives. | 2009 | Antimicrob. Agents Chemother. | pmid:19188396 |
| Nielsen A et al. | Method for screening compounds that influence virulence gene expression in Staphylococcus aureus. | 2010 | Antimicrob. Agents Chemother. | pmid:19917763 |
| Nash KA et al. | A novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae. | 2009 | Antimicrob. Agents Chemother. | pmid:19171799 |
| Mazzei T et al. | Pharmacokinetics of dirithromycin in patients with mild or moderate cirrhosis. | 1999 | Antimicrob. Agents Chemother. | pmid:10390202 |
| Azoulay-Dupuis E et al. | Efficacy of cethromycin, a new ketolide, against Streptococcus pneumoniae susceptible or resistant to erythromycin in a murine pneumonia model. | 2006 | Antimicrob. Agents Chemother. | pmid:16940099 |
| Ardanuy C et al. | Increase of the M phenotype among erythromycin-resistant Streptococcus pneumoniae isolates from Spain related to the serotype 14 variant of the Spain9V-3 clone. | 2006 | Antimicrob. Agents Chemother. | pmid:16940119 |
| Patamasucon P et al. | Pharmacokinetics of erythromycin ethylsuccinate and estolate in infants under 4 months of age. | 1981 | Antimicrob. Agents Chemother. | pmid:6975059 |
| Achard A et al. | Emergence of macrolide resistance gene mph(B) in Streptococcus uberis and cooperative effects with rdmC-like gene. | 2008 | Antimicrob. Agents Chemother. | pmid:18519724 |
| Mascio CT et al. | Bactericidal action of daptomycin against stationary-phase and nondividing Staphylococcus aureus cells. | 2007 | Antimicrob. Agents Chemother. | pmid:17923487 |
| Schwaiger K and Bauer J | Detection of the erythromycin rRNA methylase gene erm(A) in Enterococcus faecalis. | 2008 | Antimicrob. Agents Chemother. | pmid:18505854 |
| Morio F et al. | Antimicrobial susceptibilities and clinical sources of Dialister species. | 2007 | Antimicrob. Agents Chemother. | pmid:17923492 |
| Bingen E et al. | Telithromycin susceptibility and genomic diversity of macrolide-resistant serotype III group B streptococci isolated in perinatal infections. | 2004 | Antimicrob. Agents Chemother. | pmid:14742237 |
| Sakata H et al. | The effect of antimicrobial agents on fecal flora of children. | 1986 | Antimicrob. Agents Chemother. | pmid:3087275 |
| Noel GJ and Teele DW | In vitro activities of selected new and long-acting cephalosporins against Pasteurella multocida. | 1986 | Antimicrob. Agents Chemother. | pmid:3087279 |
| Blais J et al. | Inhibition of Toxoplasma gondii protein synthesis by azithromycin. | 1993 | Antimicrob. Agents Chemother. | pmid:8215287 |
| Dever LL et al. | Comparative in vitro activities of clarithromycin, azithromycin, and erythromycin against Borrelia burgdorferi. | 1993 | Antimicrob. Agents Chemother. | pmid:8215288 |
| Johnson SR et al. | In Vitro selection of Neisseria gonorrhoeae mutants with elevated MIC values and increased resistance to cephalosporins. | 2014 | Antimicrob. Agents Chemother. | pmid:25199775 |
| Conte JE et al. | Intrapulmonary pharmacokinetics of clarithromycin and of erythromycin. | 1995 | Antimicrob. Agents Chemother. | pmid:7726492 |
| Hsueh PR et al. | High incidence of erythromycin resistance among clinical isolates of Streptococcus agalactiae in Taiwan. | 2001 | Antimicrob. Agents Chemother. | pmid:11600380 |
| Nagai K et al. | Activities of a new fluoroketolide, HMR 3787, and its (des)-fluor derivative RU 64399 compared to those of telithromycin, erythromycin A, azithromycin, clarithromycin, and clindamycin against macrolide-susceptible or -resistant Streptococcus pneumoniae and S. pyogenes. | 2001 | Antimicrob. Agents Chemother. | pmid:11600391 |
| Okamoto H et al. | In vivo efficacy of telithromycin (HMR3647) against Streptococcus pneumoniae and Haemophilus influenzae. | 2001 | Antimicrob. Agents Chemother. | pmid:11600393 |
| Miller AA et al. | Discovery and characterization of QPT-1, the progenitor of a new class of bacterial topoisomerase inhibitors. | 2008 | Antimicrob. Agents Chemother. | pmid:18519725 |
| Wolff BJ et al. | Detection of macrolide resistance in Mycoplasma pneumoniae by real-time PCR and high-resolution melt analysis. | 2008 | Antimicrob. Agents Chemother. | pmid:18644962 |
| Joo HS et al. | Subinhibitory concentrations of protein synthesis-inhibiting antibiotics promote increased expression of the agr virulence regulator and production of phenol-soluble modulin cytolysins in community-associated methicillin-resistant Staphylococcus aureus. | 2010 | Antimicrob. Agents Chemother. | pmid:20713669 |
| Rikihisa Y and Jiang BM | In vitro susceptibilities of Ehrlichia risticii to eight antibiotics. | 1988 | Antimicrob. Agents Chemother. | pmid:3142345 |
| Bérubé D et al. | Plasma bactericidal activity after administration of erythromycin estolate and erythromycin ethylsuccinate to healthy volunteers. | 1988 | Antimicrob. Agents Chemother. | pmid:3142349 |
| Lawrence L et al. | In vitro activities of the Rx-01 oxazolidinones against hospital and community pathogens. | 2008 | Antimicrob. Agents Chemother. | pmid:18316525 |
| Robertson JA et al. | Standardized method for determining antimicrobial susceptibility of strains of Ureaplasma urealyticum and their response to tetracycline, erythromycin, and rosaramicin. | 1981 | Antimicrob. Agents Chemother. | pmid:7283415 |
| Mushtaq A et al. | Differential Antimicrobial Susceptibilities of Granulicatella adiacens and Abiotrophia defectiva. | 2016 | Antimicrob. Agents Chemother. | pmid:27216060 |
| DiSanto AR and Chodos DJ | Influence of study design in assessing food effects on absorption of erythromycin base and erythromycin stearate. | 1981 | Antimicrob. Agents Chemother. | pmid:7283417 |
| Truong-Bolduc QC et al. | Transcriptional Regulator TetR21 Controls the Expression of the Staphylococcus aureus LmrS Efflux Pump. | 2017 | Antimicrob. Agents Chemother. | pmid:28584148 |
| Blackwell GA and Hall RM | The Determinant and the Genes in Acinetobacter Plasmids Are Each Part of Discrete Modules Flanked by Inversely Oriented p (XerC-XerD) Sites. | 2017 | Antimicrob. Agents Chemother. | pmid:28533235 |
| Tiemei Z et al. | Resistance phenotypes and genotypes of erythromycin-resistant Streptococcus pneumoniae isolates in Beijing and Shenyang, China. | 2004 | Antimicrob. Agents Chemother. | pmid:15388475 |
| Jiang LJ et al. | Pharmacokinetics of EDP-420 after ascending single oral doses in healthy adult volunteers. | 2009 | Antimicrob. Agents Chemother. | pmid:19223626 |
| Ji B et al. | Effectiveness of clarithromycin and minocycline alone and in combination against experimental Mycobacterium leprae infection in mice. | 1991 | Antimicrob. Agents Chemother. | pmid:1828136 |
| Nagai K et al. | Susceptibility to telithromycin in 1,011 Streptococcus pyogenes isolates from 10 central and Eastern European countries. | 2002 | Antimicrob. Agents Chemother. | pmid:11796375 |
| Azoulay-Dupuis E et al. | Prophylactic and therapeutic activities of azithromycin in a mouse model of pneumococcal pneumonia. | 1991 | Antimicrob. Agents Chemother. | pmid:1656849 |
| Amacher DE et al. | Comparison of the effects of the new azalide antibiotic, azithromycin, and erythromycin estolate on rat liver cytochrome P-450. | 1991 | Antimicrob. Agents Chemother. | pmid:1656856 |
| Terekhova D et al. | Erythromycin resistance in Borrelia burgdorferi. | 2002 | Antimicrob. Agents Chemother. | pmid:12384380 |
| Wang H et al. | High prevalence of fluoroquinolone-resistant group B streptococci among clinical isolates in China and predominance of sequence type 19 with serotype III. | 2013 | Antimicrob. Agents Chemother. | pmid:23295933 |
| Wingard JB et al. | A novel cell-associated protection assay demonstrates the ability of certain antibiotics to protect ocular surface cell lines from subsequent clinical Staphylococcus aureus challenge. | 2011 | Antimicrob. Agents Chemother. | pmid:21628536 |
| Brueggemann AB et al. | In vitro activity of ABT-773, a new ketolide, against recent clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. | 2000 | Antimicrob. Agents Chemother. | pmid:10639382 |
| Gould IM et al. | Interaction of imipenem with erythromycin and tetracycline assessed by microdilution checkerboard techniques. | 1991 | Antimicrob. Agents Chemother. | pmid:1804015 |
| Allen NE | Macrolide resistance in Staphylococcus aureus: inducers of macrolide resistance. | 1977 | Antimicrob. Agents Chemother. | pmid:856018 |
| Benson CA et al. | In vitro activity of A-56268 (TE-031), a new macrolide, compared with that of erythromycin and clindamycin against selected gram-positive and gram-negative organisms. | 1987 | Antimicrob. Agents Chemother. | pmid:2952063 |
| Barry AL et al. | In vitro activity of a new macrolide, A-56268, compared with that of roxithromycin, erythromycin, and clindamycin. | 1987 | Antimicrob. Agents Chemother. | pmid:2952064 |
| Shungu DL et al. | In vitro antibacterial activity of norfloxacin (MK-0366, AM-715) and other agents against gastrointestinal tract pathogens. | 1983 | Antimicrob. Agents Chemother. | pmid:6219622 |
| Veiga-Crespo P et al. | Synergism between outer membrane proteins and antimicrobials. | 2011 | Antimicrob. Agents Chemother. | pmid:21321143 |
| Barry AL et al. | In vitro activities of azithromycin (CP 62,993), clarithromycin (A-56268; TE-031), erythromycin, roxithromycin, and clindamycin. | 1988 | Antimicrob. Agents Chemother. | pmid:2840016 |
| Araujo FG et al. | Azithromycin, a macrolide antibiotic with potent activity against Toxoplasma gondii. | 1988 | Antimicrob. Agents Chemother. | pmid:2840017 |
| Srinivasan VB et al. | Role of AbeS, a novel efflux pump of the SMR family of transporters, in resistance to antimicrobial agents in Acinetobacter baumannii. | 2009 | Antimicrob. Agents Chemother. | pmid:19770280 |
| Lehtopolku M et al. | Antimicrobial susceptibilities of multidrug-resistant Campylobacter jejuni and C. coli strains: in vitro activities of 20 antimicrobial agents. | 2010 | Antimicrob. Agents Chemother. | pmid:20038624 |
| Wong H et al. | Characterization of ermA in macrolide-susceptible strains of methicillin-resistant Staphylococcus aureus. | 2009 | Antimicrob. Agents Chemother. | pmid:19487445 |
| Severin JA et al. | Nasal carriage of methicillin-resistant and methicillin-sensitive strains of Staphylococcus sciuri in the Indonesian population. | 2010 | Antimicrob. Agents Chemother. | pmid:20837756 |
| Jeong JW et al. | In vitro and in vivo activities of LCB01-0371, a new oxazolidinone. | 2010 | Antimicrob. Agents Chemother. | pmid:20855730 |
| Chakraborty A et al. | In vitro sensitivity and resistance of 46 Leptospira strains isolated from rats in the Philippines to 14 antimicrobial agents. | 2010 | Antimicrob. Agents Chemother. | pmid:20855741 |
| Duarte RS et al. | Distribution of antimicrobial resistance and virulence-related genes among Brazilian group B streptococci recovered from bovine and human sources. | 2005 | Antimicrob. Agents Chemother. | pmid:15616281 |
| Donati M et al. | In vitro activities of several antimicrobial agents against recently isolated and genotyped Chlamydia trachomatis urogenital serovars D through K. | 2010 | Antimicrob. Agents Chemother. | pmid:20855744 |
| Xiong L et al. | Binding site of the bridged macrolides in the Escherichia coli ribosome. | 2005 | Antimicrob. Agents Chemother. | pmid:15616307 |
| Floyd JL et al. | LmrS is a multidrug efflux pump of the major facilitator superfamily from Staphylococcus aureus. | 2010 | Antimicrob. Agents Chemother. | pmid:20855745 |
| Abbanat D et al. | In vitro activities of novel 2-fluoro-naphthyridine-containing ketolides. | 2005 | Antimicrob. Agents Chemother. | pmid:15616310 |
| Andremont A et al. | Epidemiology of intestinal colonization by members of the family Enterobacteriaceae highly resistant to erythromycin in a hematology-oncology unit. | 1986 | Antimicrob. Agents Chemother. | pmid:3729363 |